Dentarina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 44,969 | 44,657 | 31,264 | 36,795 | 43,652 | 44,625 | 43,530 | 44,071 |
| Profit before tax | - | - | 2,313 | 13 | 373 | -15,337 | -20,770 | -28,278 |
| Net profit | 72 | 35 | 2,197 | 12 | 354 | -15,337 | -20,770 | -28,278 |
| Equity | 31,085 | 30,633 | 32,561 | 31,543 | 30,475 | 28,328 | 29,018 | 26,298 |
| Liabilities | 966 | 1,372 | 893 | 924 | 4,574 | 1,775 | 1,424 | 4,166 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 21,746 | 21,785 | 23,234 | 22,247 | 24,829 | 19,883 | 20,222 | 20,244 |
| Total assets | 21,746 | 21,785 | 23,234 | 22,247 | 24,829 | 19,883 | 20,222 | 20,244 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,872 | 9,534 | 10,292 |
| Social insurance contributions | - | - | - | - | - | - | - | 1,432 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +6.7% | -0.7% | -30.0% | +17.7% | +18.6% | +2.2% | -2.5% | +1.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.3% | 0.2% | 9.5% | 0.1% | 1.4% | -77.1% | -102.7% | -139.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.2% | 0.1% | 6.7% | 0.0% | 1.2% | -54.1% | -71.6% | -107.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.2% | 0.1% | 7.0% | 0.0% | 0.8% | -34.4% | -47.7% | -64.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 7.4% | 0.0% | 0.9% | -34.4% | -47.7% | -64.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 11,242 | 11,164 | 7,816 | 9,199 | 14,551 | 14,875 | 14,510 | 14,690 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dentarina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-21 | 2026-02-05 | 0.25 |
| 2026-01-16 | 2026-01-20 | 0.01 |
| 2026-01-01 | 2026-01-12 | 0.01 |
| 2025-12-16 | 2025-12-30 | 0.01 |
| 2025-11-18 | 2025-12-11 | 0.01 |
| 2025-10-16 | 2025-11-12 | 0.01 |
| 2025-09-07 | 2025-10-12 | 0.01 |
| 2025-08-31 | 2025-09-03 | 0.01 |
| 2025-08-19 | 2025-08-29 | 0.01 |
| 2025-04-24 | 2025-04-29 | 0.02 |
| 2025-02-10 | 2025-02-10 | 5.99 |
| 2025-01-16 | 2025-01-27 | 5.99 |
| 2023-06-16 | 2023-07-13 | 0.02 |
| 2023-05-16 | 2023-06-08 | 0.02 |
| 2023-05-02 | 2023-05-08 | 0.02 |
| 2023-04-18 | 2023-04-28 | 0.02 |
| 2023-03-16 | 2023-04-02 | 0.13 |
| 2023-02-17 | 2023-03-13 | 0.01 |
| 2022-03-16 | 2022-04-04 | 0.01 |
Dentarina - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-03 | 2026-02-16 | 0.24 |
| 2025-12-18 | 2025-12-29 | 0.24 |
| 2025-11-20 | 2025-12-09 | 0.24 |
| 2025-11-02 | 2025-11-09 | 0.24 |
| 2025-05-19 | 2025-06-04 | 1.12 |
| 2025-05-01 | 2025-05-01 | 1.12 |
| 2025-04-30 | 2025-04-30 | 0.42 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dentarina, UAB (company code 302807675) is a private limited liability company operating in the wholesale of pharmaceutical and medical goods. In 2025, it generated revenue of €44.1K, keeping sales broadly stable over the last three years. Revenue amounted to €44.6K in 2023, €43.5K in 2024 and €44.1K in 2025, which indicates a modest 1.2% year-on-year increase and a 1.2% decline over two years. Profitability remained under pressure throughout the period. Net loss widened from €15.3K in 2023 to €20.8K in 2024 and €28.3K in 2025, with the latest profit margin at -64.2%. The balance sheet stayed small, with total assets of €20.2K in 2025, equity of €26.3K and liabilities of €4.2K. Reported asset turnover was 2.18x and debt-to-equity was 0.16. Revenue per employee stood at €14.7K, while profit per employee was -€9.4K. Return on equity and return on assets were strongly negative in 2025, reflecting the continuing losses.